Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000004193
JPRN-UMIN000004193Completed未知

Effectiveness of Metformin and Lifestyle Interventions as Initial Treatment in Japanese Patients with Type 2 Diabetes (EMINENT Study) - Effectiveness of Metformin and Lifestyle Interventions as Initial Treatment in Japanese Patients with Type 2 Diabetes (EMINENT Study)

issay Hospital0 sites20 target enrollmentStarted: September 22, 2010Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
20
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Satoru Sumitani, Shinya Morita, Yoshihiko Utsu, Kosuke Mukai, Shunji Miki, Bunzo Sato, Hideji Nakamura, Soji Kasayama. Effectiveness of metformin and lifestyle interventions asan initial treatment in Japanese patients with newly diagnosed type 2 diabetes : a prospective observational study. J. Med. Invest. 59 : 166-173, February, 2012

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Type 1 diabetes. Patients contraindicated to metformin. Patients judged not to be eligible by the principal investigator.

Investigators

Sponsor
issay Hospital

Similar Trials

Recruiting
Phase 3
Effects of metformin and lifestyle modifications on the progression of the atherosclerosis among individuals with impaired glucose tolerancePre-diabetes
SLCTR/2016/026niversity Grants Commission, Sri Lanka
Completed
Not Applicable
Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome, A Pilot Randomized Controlled TrialInfertility, FemaleObesityInsulin Resistance
NCT03898037Reproductive & Genetic Hospital of CITIC-Xiangya80
Not yet recruiting
Phase 2
Metformin treatment among pregnant women with fatty liver condition to prevent diabetes during pregnancy
CTRI/2023/12/060930Directorate of Health Research
Not yet recruiting
Unknown
Benefit of metformin for weight control and related parameters in obese patients of schizophrenia
CTRI/2023/09/057609Government Medical College and Hospital Chandigarh
Completed
Not Applicable
A Treatment Legacy Effect of Metformin in Obese Women With PCOSPCOS
NCT04566718University Medical Centre Ljubljana40